BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 31865966)

  • 1. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
    Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
    Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.
    Schachtl-Riess JF; Kheirkhah A; Grüneis R; Di Maio S; Schoenherr S; Streiter G; Losso JL; Paulweber B; Eckardt KU; Köttgen A; Lamina C; Kronenberg F; Coassin S;
    J Am Coll Cardiol; 2021 Aug; 78(5):437-449. PubMed ID: 34325833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
    Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
    J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).
    Stefanutti C; Pisciotta L; Favari E; Di Giacomo S; Vacondio F; Zenti MG; Morozzi C; Berretti D; Mesce D; Vitale M; Pasta A; Ronca A; Garuti A; Manfredini M; Anglés-Cano E; Marcovina SM; Watts GF;
    J Clin Lipidol; 2020; 14(4):487-497.e1. PubMed ID: 32718857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin.
    Buchmann N; Scholz M; Lill CM; Burkhardt R; Eckardt R; Norman K; Loeffler M; Bertram L; Thiery J; Steinhagen-Thiessen E; Demuth I
    Acta Diabetol; 2017 Nov; 54(11):1031-1038. PubMed ID: 28866807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
    Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
    Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.
    Gambhir JK; Kaur H; Prabhu KM; Morrisett JD; Gambhir DS
    Clin Biochem; 2008 May; 41(7-8):453-8. PubMed ID: 18280807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
    Kronenberg F
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?
    Ye Z; Haycock PC; Gurdasani D; Pomilla C; Boekholdt SM; Tsimikas S; Khaw KT; Wareham NJ; Sandhu MS; Forouhi NG
    Diabetes; 2014 Jan; 63(1):332-342. PubMed ID: 24089516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Grüneis R; Lamina C; Di Maio S; Schönherr S; Zoescher P; Forer L; Streiter G; Peters A; Gieger C; Köttgen A; Kronenberg F; Coassin S
    Atherosclerosis; 2022 May; 349():151-159. PubMed ID: 35534298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a): resurrected by genetics.
    Kronenberg F; Utermann G
    J Intern Med; 2013 Jan; 273(1):6-30. PubMed ID: 22998429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic
    Guertin J; Kaiser Y; Manikpurage H; Perrot N; Bourgeois R; Couture C; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Clavel MA; Thériault S; Boekholdt SM; Arsenault BJ
    Circ Genom Precis Med; 2021 Aug; 14(4):e003271. PubMed ID: 34279996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
    Kraft HG; Lingenhel A; Köchl S; Hoppichler F; Kronenberg F; Abe A; Mühlberger V; Schönitzer D; Utermann G
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):713-9. PubMed ID: 8640397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.